CLINICAL_TRIALS
trial_result
· 2015-02-26
Clinical Trial Update: An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment [Phase 3]
Summary
Results from an open-label Phase 3 study of tocilizumab in rheumatoid arthritis have been completed, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2015-02-26